The Triple Point Venture VCT

Fund Overview

Triple Point Venture VCT invests in high-growth early-stage UK businesses, focusing on technology-driven innovation. The fund seeks to identify and support businesses with scalable business models that address significant market opportunities. As of September 2023, the Triple Point Venture VCT had net assets of £62 million, providing investors with exposure to dynamic companies while delivering tax-efficient returns.

Investment Strategy

The Triple Point Venture VCT focuses on venture capital investments in early-stage businesses across the UK. Managed by Triple Point Investment Management, the fund prioritizes opportunities in technology, healthcare, and sustainability, leveraging Triple Point's expertise in sourcing and scaling promising startups.

Key Elements of the Strategy:

  1. Sector Focus:

    • Technology: Backing companies in SaaS, artificial intelligence, and digital transformation.
    • Healthcare: Supporting innovations in medtech and life sciences.
    • Sustainability: Investing in businesses contributing to environmental and social impact.
    • Consumer Goods: Identifying brands with unique propositions and high-growth potential.
  2. Investment Criteria:

    • Scalable, disruptive technologies addressing large market opportunities.
    • Companies with strong leadership and clear growth trajectories.
    • Early-stage businesses with potential for significant value creation.
  3. Portfolio Diversification:

    • Targets a balanced portfolio of 50-60 companies across various sectors.
    • Focuses on spreading risk across high-growth industries.
  4. Geographic Focus:

    • Primarily UK-based startups, with emphasis on regional innovation hubs.

Recent Investments and Focus Areas:

  • Tech-Driven Growth: Investments in AI-based platforms addressing enterprise needs.
  • Sustainability Initiatives: Companies developing renewable energy solutions and carbon reduction technologies.
  • Healthcare Innovation: Firms creating solutions for enhanced diagnostics and patient care.

How This Benefits Investors:

By targeting high-growth startups, Triple Point Venture VCT provides investors with exposure to disruptive innovation and the potential for substantial capital appreciation.

Performance Metrics

Year NAV Total Return (%) Dividends Paid (p/share)
2024 8.0 3.5
2023 7.2 3.0
2022 6.5 2.5

Note: NAV Total Return is calculated as the sum of NAV growth and dividends paid.

Tax Benefits

Investors benefit from:

  • 30% income tax relief: Available on investments up to £200,000 annually.
  • Tax-free dividends: Regular income payments without tax obligations.
  • Capital gains tax exemption: No CGT on share disposals.

Tax treatment depends on individual circumstances and may change in the future.

Contact Information

Why Consider Access EIS Instead?

Both Triple Point Venture VCT and Access EIS offer tax-efficient ways to invest in innovative UK businesses, but they cater to different investment needs:

Feature Triple Point Venture VCT Access EIS
Investment Focus Early-stage UK businesses across technology, healthcare, and sustainability Early-stage, high-growth UK startups
Minimum Investment £3,000 £5,000
Tax Benefits - 30% Income Tax Relief
- Tax-Free Dividends
- Capital Gains Tax Exemption
- 30% Income Tax Relief
- Capital Gains Tax Deferral
Liquidity Some liquidity via buyback schemes Illiquid, with returns realized after ~5–7 years
Dividends Regular, tax-free dividends No dividends; all profits reinvested
Risk Level High (early-stage companies) Very High (early-stage startups)

Learn More About Access EIS